RhumbLine Advisers’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.83M | Buy |
520,130
+58,846
| +13% | +$188K | ﹤0.01% | 1906 |
|
|
2025
Q4 | $1.26M | Buy |
461,284
+67,207
| +17% | +$155K | ﹤0.01% | 2113 |
|
|
2025
Q3 | $855K | Sell |
394,077
-16,418
| -4% | -$38.8K | ﹤0.01% | 2335 |
|
|
2025
Q2 | $706K | Buy |
410,495
+21,314
| +5% | +$53K | ﹤0.01% | 2437 |
|
|
2025
Q1 | $1.3M | Buy |
389,181
+3,411
| +0.9% | +$17.6K | ﹤0.01% | 2053 |
|
|
2024
Q4 | $2.85M | Buy |
385,770
+31,699
| +9% | +$294K | ﹤0.01% | 1708 |
|
|
2024
Q3 | $3.32M | Sell |
354,071
-14,729
| -4% | -$140K | ﹤0.01% | 1627 |
|
|
2024
Q2 | $2.96M | Sell |
368,800
-22,750
| -6% | -$244K | ﹤0.01% | 1678 |
|
|
2024
Q1 | $5.8M | Buy |
391,550
+23,094
| +6% | +$269K | 0.01% | 1336 |
|
|
2023
Q4 | $3M | Buy |
368,456
+16,289
| +5% | +$85.2K | ﹤0.01% | 1699 |
|
|
2023
Q3 | $1.6M | Sell |
352,167
-12,476
| -3% | -$81.5K | ﹤0.01% | 1967 |
|
|
2023
Q2 | $2.57M | Buy |
364,643
+124,752
| +52% | +$893K | ﹤0.01% | 1767 |
|
|
2023
Q1 | $1.47M | Buy |
239,891
+5,214
| +2% | +$36K | ﹤0.01% | 1968 |
|
|
2022
Q4 | $1.5M | Sell |
234,677
-2,452
| -1% | -$19.1K | ﹤0.01% | 1937 |
|
|
2022
Q3 | $2.27M | Buy |
237,129
+16,185
| +7% | +$187K | ﹤0.01% | 1683 |
|
|
2022
Q2 | $2.44M | Buy |
220,944
+97,707
| +79% | +$1.28M | ﹤0.01% | 1667 |
|
|
2022
Q1 | $2.05M | Sell |
123,237
-11,282
| -8% | -$174K | ﹤0.01% | 1806 |
|
|
2021
Q4 | $2.57M | Buy |
134,519
+4,603
| +4% | +$101K | ﹤0.01% | 1743 |
|
|
2021
Q3 | $3.2M | Sell |
129,916
-9,937
| -7% | -$234K | ﹤0.01% | 1625 |
|
|
2021
Q2 | $3.64M | Buy |
139,853
+2,703
| +2% | +$70.3K | ﹤0.01% | 1618 |
|
|
2021
Q1 | $4.34M | Sell |
137,150
-8,039
| -6% | -$333K | 0.01% | 1481 |
|
|
2020
Q4 | $6.74M | Sell |
145,189
-1,249
| -0.9% | -$49.6K | 0.01% | 1178 |
|
|
2020
Q3 | $4.82M | Sell |
146,438
-8,171
| -5% | -$251K | 0.01% | 1192 |
|
|
2020
Q2 | $4.24M | Sell |
154,609
-10,773
| -7% | -$354K | 0.01% | 1302 |
|
|
2020
Q1 | $4.95M | Buy |
165,382
+4,081
| +3% | +$108K | 0.01% | 1034 |
|
|
2019
Q4 | $4.46M | Buy |
161,301
+6,498
| +4% | +$148K | 0.01% | 1319 |
|
|
2019
Q3 | $2.82M | Sell |
154,803
-405
| -0.3% | -$8.96K | 0.01% | 1540 |
|
|
2019
Q2 | $3.81M | Buy |
155,208
+19,978
| +15% | +$301K | 0.01% | 1349 |
|
|
2019
Q1 | $1.29M | Sell |
135,230
-858
| -0.6% | -$8.33K | ﹤0.01% | 1915 |
|
|
2018
Q4 | $1.2M | Buy |
136,088
+64,879
| +91% | +$626K | ﹤0.01% | 1916 |
|
|
2018
Q3 | $801K | Sell |
71,209
-5,215
| -7% | -$74K | ﹤0.01% | 2094 |
|
|
2018
Q2 | $978K | Buy |
76,424
+5,465
| +8% | +$79.9K | ﹤0.01% | 2021 |
|
|
2018
Q1 | $1.2M | Buy |
70,959
+15,241
| +27% | +$231K | ﹤0.01% | 1859 |
|
|
2017
Q4 | $446K | Sell |
55,718
-8,347
| -13% | -$67K | ﹤0.01% | 2280 |
|
|
2017
Q3 | $497K | Buy |
64,065
+365
| +0.6% | +$2.31K | ﹤0.01% | 2309 |
|
|
2017
Q2 | $468K | Buy |
63,700
+5,030
| +9% | +$32K | ﹤0.01% | 2340 |
|
|
2017
Q1 | $437K | Buy |
58,670
+2,421
| +4% | +$17.7K | ﹤0.01% | 2308 |
|
|
2016
Q4 | $391K | Buy |
56,249
+7,033
| +14% | +$48.4K | ﹤0.01% | 2352 |
|
|
2016
Q3 | $405K | Sell |
49,216
-3,060
| -6% | -$25.9K | ﹤0.01% | 2315 |
|
|
2016
Q2 | $423K | Buy |
52,276
+7,276
| +16% | +$45.7K | ﹤0.01% | 2308 |
|
|
2016
Q1 | $229K | Buy |
45,000
+575
| +1% | +$3.15K | ﹤0.01% | 2671 |
|
|
2015
Q4 | $343K | Buy |
44,425
+3,440
| +8% | +$23.9K | ﹤0.01% | 2487 |
|
|
2015
Q3 | $236K | Buy |
40,985
+3,515
| +9% | +$27.4K | ﹤0.01% | 2693 |
|
|
2015
Q2 | $344K | Buy |
+37,470
| New | +$418K | ﹤0.01% | 2564 |
|
Other funds holding IOVA
MFM
VCM
VPM
ICM